New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

en_US EN
en_US EN es_MX ES

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Home / Managing RKD / Clinical Trials

Clinical Trials

Participating in a clinical trial gives you access to cutting-edge treatments and expert care, while helping advance research that could benefit countless others. You’ll be closely monitored by top physicians throughout the trial to ensure your safety, and if the treatment proves effective, you could be among the first to benefit. Your involvement today helps shape the future of kidney disease care. To learn more about current trials and how to get involved, visit our clinical trial resources.

Find a Clinical Trial That is Right for You

Use our clinical trial matching tool to see if you match to any rare kidney diseases (RKD) clinical trials. Just answer a few quick questions, and we’ll help connect you to trials that may be right for you. Your participation could lead to better treatments and hope for the RKD community.

What is your diagnosis?
Please assume that the conditions listed are "Primary" or Idiopathic". If you have a genetic mutation, we will consider it to be "Primary" for the purposes of the question.
Have you ever had a kidney transplant?
Are you currently on dialysis?
Are you currently spilling protein?
Did you have a biopsy to confirm your diagnosis?
Search for trials near me:
What is your current eGFR?
What was your latest UPCR (urine protein to creatinine ratio)?
What treatments have you taken for your disease?
Are you considered one of the following?
Are you currently on the transplant wait-list?
Disclaimer
The “Am I A Match?” tool is designed solely to help filter the clinical trials listed below based on your responses.

Filter Results By

Download List of

Clinical Trials

Generate a custom PDF of clinical trials based on your selected filters. Choose disease types or other filter options, and download a tailored list that meets your search criteria.

Download PDF

Want to Learn More about Clinical Trials?

Explore these resources to better understand what to expect during a trial, so you can feel informed.

View Resources

New Trials

PODOMOUNT-pFSGS
The PODOMOUNT-pFSGS study is evaluating whether an investigational once daily oral medication called apecotrep reduces the amount of protein in the urine in adult patients...

Currently Enrolling

Interventional

FSGS

Adult

Pediatric

Learn More

All Clinical Trials

Download Clinical Trials
Searching for nearby trials...
This may take a moment
ACTION3
The ACTION3 Study will examine if the investigational medicine, DMX-200 (repagermanium), reduces the amount of proteinuria (protein in your urine) and slows the decline of...

Currently Enrolling

Interventional

FSGS

Pediatric

Learn More
AUTUMN
The AUTUMN Study is for adults living with primary membranous nephropathy (PMN), a rare kidney condition that can cause swelling in your lower body, tiredness, changes in...

Not yet recruiting

Interventional

MEMBRANOUS NEPHROPATHY

Adult

Learn More
APPRECIATE Study
The purpose of this study is to learn more about the safety, tolerability, and effectiveness of AZD2373 and to better understand AMKD and associated health problems.

Currently Enrolling

Interventional

APOL1

FSGS

Adult

Learn More
PREVAIL
In this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). This study will focus on participants who...

Currently Enrolling

Interventional

IgA NEPHROPATHY

Adult

Learn More
PROMINENT
The main goal of this study is to compare how felzartamab works compared to a drug called tacrolimus in participants with PMN

Currently Enrolling

Interventional

MEMBRANOUS NEPHROPATHY

Adult

Learn More
PODOMOUNT-Basket
The PODOMOUNT-Basket study is evaluating whether an investigational once daily oral medication called Apecotrep reduces the amount of protein in the urine in adult patients...

Currently Enrolling

Interventional

FSGS

MEMBRANOUS NEPHROPATHY

MINIMAL CHANGE DISEASE

Adult

Pediatric

Learn More

Sponsors

We would like to extend our sincere gratitude to our sponsors. Thank you for your commitment and dedication to our cause. 

Silver

Bronze

Headline decoration line

Careers

Explore career opportunities at NephCure, where passion meets purpose. Our dedicated team is committed to advancing research, supporting patients, and raising awareness for rare kidney diseases. Explore rewarding career opportunities today.

JOIN THE TEAM

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.
NephCure Logo

INTRO TO RKD

Overview
Types of RKD
Navigating New Diagnosis
Pediatric Care
End-Stage Kidney Disease

SUPPORT

Patient Navigation Services
Online Patient Community
Patient Stories
Support Groups
Resources

MANAGING RKD

Find a Specialist
Clinical Trials
Treatment Options
RKD & Mental Health
Diet & Nutrition
Genetic Testing

LEGAL

Careers
Privacy Policy
Policies & Disclaimers
Financials

ABOUT US

Our Impact
What We Do
Team
Current Partnerships
News
Contact Us

GET INVOLVED

Volunteer
Events
Advocacy
Find your Local Community
Ways to Give

Our Mission

NephCure’s mission is to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible.

Find Us On

NephCure is a registered non-profit (501c3) tax-exempt charitable organization. EIN # 38-3569922.
© Copyright 2024 NephCure, Inc. All rights reserved worldwide. NephCure, and the logo, are federally registered trademarks of NephCure, Inc.